Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-03-28
2006-03-28
Minnifield, N. M. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023400, C435S069300, C435S252300, C435S254110, C435S320100, C514S04400A, C530S350000
Reexamination Certificate
active
07019125
ABSTRACT:
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae, employing a vector containing a nucleotide sequence encoding an omp P6 precursor of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the omp P6 precursor in the host. Modifications are possible within the scope of this invention.
REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5364773 (1994-11-01), Paoletti et al.
patent: 6235290 (2001-05-01), Brunham
patent: 6403101 (2002-06-01), Murdin et al.
patent: 6403102 (2002-06-01), Murdin et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 6605287 (2003-08-01), Kousoulas et al.
patent: 6607730 (2003-08-01), Murdin et al.
patent: 6635746 (2003-10-01), Murdin et al.
patent: 6642025 (2003-11-01), Murdin et al.
patent: 6649370 (2003-11-01), Murdin et al.
patent: 6660275 (2003-12-01), Murdin et al.
patent: 6676949 (2004-01-01), Brunham et al.
patent: 6686339 (2004-02-01), Murdin et al.
patent: 6693087 (2004-02-01), Murdin et al.
patent: 6696421 (2004-02-01), Brunham
patent: 6808713 (2004-10-01), Murdin et al.
patent: 6811783 (2004-11-01), Murdin et al.
patent: 2002/0037293 (2002-03-01), Murdin et al.
patent: 2002/0071831 (2002-06-01), Murdin et al.
patent: 2002/0082402 (2002-06-01), Murdin et al.
patent: 2002/0091096 (2002-07-01), Murdin et al.
patent: 2002/0094965 (2002-07-01), Murdin et al.
patent: 2002/0099188 (2002-07-01), Murdin et al.
patent: 2002/0102270 (2002-08-01), Murdin et al.
patent: 2002/0123067 (2002-09-01), Murdin et al.
patent: 2002/0132994 (2002-09-01), Murdin et al.
patent: 2002/0150591 (2002-10-01), Murdin et al.
patent: 2003/0095973 (2003-05-01), Murdin et al.
patent: 2003/0100706 (2003-05-01), Murdin et al.
patent: 2003/0157123 (2003-08-01), Murdin et al.
patent: 2003/0157124 (2003-08-01), Murdin et al.
patent: 2003/0161833 (2003-08-01), Murdin et al.
patent: WO 95/12411 (1995-05-01), None
patent: WO 97/46709 (1997-12-01), None
patent: WO 98/02546 (1998-01-01), None
patent: WO 99/27105 (1999-06-01), None
Weinberger, Drug Discovery Today, 2004, 9/19:831-837.
Knaust et al, international J. Medical Microbiology, 2004, 294:295-301.
Genius et al, american J. Obsterics and Gynecology, 2004, 191:1103-1112.
Penttila et al, Vaccine, 2004, 22:3386-3394.
Vanrompay et al, Vaccine, 1999, 17:2628-2635.
Eko et al, Vaccine, 2003, 21:1694-1703.
Donati et al, Vaccine, 2003, 21:1089-1093.
Murdin et al, J. Infectious Diseases, 2000, 181/Suppl. 3:S544-S551.
Chakravarti et al, Vaccine, 2001, 19:601-612.
Penttila et al, Vaccine, 2001, 19:1256-1265.
Stagg, Molecular Medicine Today, Apr., 1998, pp. 166-173.
Pal et al, Vaccine, 1999, 17:459-465.
Kalman et al, Nature Genetics, 1999, 21:385-389.
Read et al, Nucleic Acids Research, 2003, 31/8:2134-2147.
Read et al, Nucleic Acids Research, 2000, 28/6:1397-1406.
Shirai et al, Nucleic Acids Research, 2000, 28/12:2311-2314.
Grayston et al. (1995) Journal of Infectious Diseases 168:1231.
Campos et al. (1995) Investigation of Ophthalmology and Visual Science 36:1477.
Marrie (1993) Clinical Infectious Diseases. 18:501.
Wang et al. (1986) Chlamydial infections. Cambridge University Press, Cambridge. p. 329.
Saikku et al. (1988) Lancet;ii:983.
Thom et al. (1992) JAMA 268:68.
Linnanmaki et al. (1993), Circulation 87:1030.
Saikku et al. (1992) Annals Internal Medicine 116:273.
Melnick et al (1993) American Journal of Medicine 95:499.
Shor et al. (1992) South African Medical Journal 82:158.
Kuo et al. (1993) Journal of Infectious Diseases 167:841.
Kuo et al. (1993) Arteriosclerosis and Thrombosis 13:1501.
Campbell et al. (1995) Journal of Infectious Diseases 172:585.
Chiu et al. (1997) Circulation. 96(7):2144-2148.
Ramirez et al. (1996) Annals of Internal Medicine 125:979.
Jackson et al. Abst. K121, p272, 36th ICAAC, Sep. 15-18, 1996, New Orleans.
Fong et al. (1997) Journal of Clinical Microbiology 35:48.
Hahn DL, et al. “Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma”. Ann Allergy Asthma Immunol. Jan. 1998; 80(1): 45-49.
Hahn DL, et al. “Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma”. Epidemiol Infect. Dec. 1996; 117(3): 513-517.
Bjornsson E, et al. “Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness”, Scand J Infect Dis. 1996; 28(1): 63-69.
Hahn DL. “Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial”. J Fam Pract. Oct. 1995; 41(4) 345-351.
Allegra L, et al. “Acute exacerbations of asthma in adults” role of Chlamydia pneumoniae infection. Eur Respir J. Dec. 1994; 7(12):2165-2168.
Hahn DL, et al. “Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma”. JAMA. Jul. 10, 1991; 266(2):225-230.
Pal et al. (1996) Infection and Immunity.64:5341.
Jones et al. (1995) Vaccine 13:715.
Igietseme et al. (1993) Regional Immunology 5:317.
Magee et al (1993) Regional Immunology 5:305.
Landers et al (1991) Infection & Immunity 59:3774.
Magee et al. (1995) Infection & Immunity 63:516.
Cotter et al. (1995) Infection and Immunity 63:4704.
Campbell et al (1990) Infection and Immunity 58:93.
McCafferty et al. (1995) Infection and Immunity 63:2387-9.
Gaydos et al.; “Similarity of Chlamydia pneumoniae strains in the Variable Domain IV Region of the Major Outer Membrane Protein Gene”; Infection and Immunity; 60(12):5319-5323. Dec. 1992.
Wiedmann-A1-Ahmad M, et al. “Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae” Clin Diagn Lab Immunol. Nov. 1997; 4(6:700-704).
Hughes et al., 1992. Infect. Immun. 60(9):3497.
Dion et al., 1990. Virology 179:474-477.
Snijders et al., 1991. J. Gen. Virol. 72:557-565.
Langeveld et al., Vaccine 12(15):1473-1480, 1994.
Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons Inc., 1994, pp. 2.9.1-2.9.15.
Kunkel et al. Proc. Natl. Acad. Sci. USA (1985) 82:448.
Silhavy et al. “Experiments with Gene Fusions”, Cold Spring Harbor Laboratory Press, 1984, pp. 191-195.
Davis et al. “A Manual for Genetic Engineering: Advanced Bacterial Genetics”, Cold Spring Harbor Laboratory Press, (1980), pp. 174-176.
Casey & Davidson, Nucl. Acid Res. (1997) 4:1539.
Cagnon et al., Protein Engineering (1991) 4(7):843.
Takase et al., J. Bact. (1987) 169:5692.
Perez Melgosa et al., Infect Immun (1994) 62:880.
Watson et al., Nucleic Acids Res (1990) 18:5299.
Watson et al., Microbiology (1995) 141:2489.
Melgosa et al., FEMS Microbiol Lett (1993) 112:199.
Campbell et al., J Clin Microbiol (1990) 28:1261.
Iijima et al., J Clin Microbiol (1994) 32:583.
http://chlamydia-www.berkeley.edu;4231/.
Bachmaier et al., Science (1999) 283:1335.
Jackson et al. 1997. J. Infect. Dis. 176:292-295.
Laitinen et al. 1997. Infect. Immun. 65:4832-4835.
Rottenberg et al. 1999. J. Immunol. 162:2829-2836.
Penttila et al. 1999. Immunology. 97:490-496.
Knudsen et al. 1999. Infect. Immun. 67:375-383.
Kalman et al., “ Comparative genomes of Chlamydia pneumoniae and Chlamydia tachomatis”, Nature. Genetics vol. 21, No. 4, pp. 385-389, 1999.
Gencore Accession Nos: AE001659 and Q9Z7C5 corresponding to 'Submitted Dec. 1, 1998, Sequence Alignments for SEQ ID No: 1 and SEQ ID No. 2.
Murdin et al. “Collaborative Multidisciplinary Workshop Report”, Journal of Infectious Diseases, vol. 181 (Suppl 3), pp. S552-S557, 2000.
Stephens, R.S., “Chlamydia Genomics and Vaccine Antigen Discovery”, J. Infect. Dis. 181(Suppl. 3), pp. S521-523, 2000.
Penttila et al., “Immunity to Chlamydia Pneumoniae induced by vaccination . . . ”, Vaccine, vol. 19, pp. 1256-1265, 2001.
Leitner et al., “DNA and RNA-based vaccines”, Vaccine, vol. 18, pp. 766-777, 2000.
“Nucleotide sequence of the complete genome of Chlamydi
Dunn Pamela
Murdin Andrew D.
Oomen Raymond P.
Wang Joe
Foley & Lardner LLP
Minnifield N. M.
Sanofi Pasteur Limited
LandOfFree
Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556424